An economic model to establish the costs associated with routes to presentation for patients with multiple myeloma in the UK

Alex Porteous,  Scott Gibson,  Lucy A. Eddowes,  Mark Drayson,  Guy Pratt,  Stella Bowcock,  Fenella Willis,  Hannah Parkin,  Suzanne Renwick,  Ira Laketic-Ljubojevic,  Debra Howell,  Alex Smith,  Simon Stern.

Value in Health Regional Issues
Volume: 35, Pages: 27-33.

A generic model for follicular lymphoma: predicting cost, life expectancy, and quality-adjusted-life-year using UK population–based observational data

Han-I Wang,  Eve Roman,  Simon Crouch,  Eline Aas,  Cathy Burton,  Russell Patmore,  Alexandra Smith.

Value in Health
Volume: 21, Issue: 10, Pages: 1176-1185.

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort

Han-I. Wang,  Alexandra Smith,  Eline Aas,  Eve Roman,  Simon Crouch,  Cathy Burton,  Russell Patmore.

The European Journal of Health Economics
Volume: 18, Issue: 2, Pages: 255-267.

Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model

Han-I Wang,  Eline Aas,  Debra Howell,  Eve Roman,  Russell Patmore,  Andrew Jack,  Alexandra Smith.

Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research
Volume: 17, Issue: 2, Pages: 205-214.